Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Congenital Multicenter Trial of Pulmonic Valve Dysfunction Studying the SAPIEN 3 Interventional THV Post-Approval Study

NCT04860765 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.

NCT NCT04860765
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04860765 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Congenital Multicenter Trial of Pulmonic Valve Dysfunction Studying the SAPIEN 3 Interventional THV Post-Approval Study
Lead sponsor
Edwards Lifesciences
Phase
Observational
Overall status
Active, not recruiting
Start date
April 13, 2021
Completion date
August 31, 2030
Enrollment
150 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

complex congenital heart defect, dysfunctional rvot conduit, pulmonary valve degeneration, pulmonary valve insufficiency, pulmonary valve; obstruction